The history of AstraZeneca
AstraZeneca's predecessor can be traced back to the beginning of19th century. Astra Company and Imirie Weng Company were established in Sweden and Britain respectively. Both companies have achieved success in their respective fields, but at the end of the 20th century, they both faced challenges from other competitors. Astra and Emile decided to merge to form AstraZeneca 1999 in order to better cope with market changes.
AstraZeneca business
AstraZeneca is a pharmaceutical company focusing on innovative drugs, and its business covers many fields, including cardiovascular, respiratory, oncology, immunology and neuroscience. AstraZeneca's R&D team is committed to developing new drugs to meet the needs of patients all over the world. AstraZeneca's products have been widely used all over the world and become the first choice for the treatment of many diseases.
Development of AstraZeneca
With the continuous progress of science and technology, AstraZeneca is also growing. The company not only invested a lot of resources in research and development, but also did a lot of work in production, sales and marketing. AstraZeneca's business has spread all over the world, and the company has thousands of employees around the world, providing quality drug treatment services for patients.
The future of AstraZeneca
In the future, AstraZeneca will continue to develop innovative drugs to provide better treatment for patients around the world. The company will continue to strengthen cooperation with global medical institutions and research institutions to promote drug research and development and clinical application. At the same time, AstraZeneca will continue to pay attention to the changes in the global pharmaceutical market, constantly optimize its business model and improve its market competitiveness.